Biotechnology

Novartis to Acquire Myricx Bio for Up to $1.5B, Adding ...

Myricx Bio specializes in developing ADCs that use N-myristoyltransferase inhibi...

Vertex Eyes Expansion Beyond Cystic Fibrosis with Plann...

Based in San Diego, Crinetics focuses on discovering, developing, and commercial...

A New Approach to Supporting Quality of Biologics

The United States Pharmacopeia (USP) is proposing a new approach for its work to...

Biotech and Biomed Engineering Grad and Certificate Pro...

Biomedical engineering focuses on developing technologies and systems that impro...

The Quest for Large-Scale DNA

As genome editing therapies move through clinical trials to regulatory approval,...

AI Reveals Hidden Brain Lesions in Multiple Sclerosis MRI

Researchers combined AI with multiple image processing methods to reliably measu...

A New Development Playbook for PROTACs

In this Thought Leader article from our July issue, Shanghao Li, PhD, explores w...

KLK1 Expands Possibilities to Restore Vascular Health

By restoring the body’s ability to produce KLK1, therapies are emerging for pree...

AI Tackles Tuberculosis, Identifies Drugs that Penetrat...

Researchers have developed a new AI approach to select chemical compounds that c...

Bioprocessing at Full Throttle

Intensified strategies are reshaping biologics manufacturing by boosting speed, ...

Biomanufacturing in Space to Be Key Topic at ISSCR 2026

Scientists from the Cedars-Sinai Board of Governors Regenerative Medicine Instit...

Unlocking Microbiome Function with Anaerobic Workflows ...

This eBook explores how researchers can move beyond correlation and towards mech...

New sa‑mRNA and LNP Platform to Support Korea’s Hantavi...

Building on promising preclinical findings, researchers in South Korea are devel...

Pharma Races to Scale AI as Billions Flow into Drug Dis...

Investors unpack what it takes to succeed in an increasingly crowded AI biology ...

Chimeric Allergen Receptor Treg Cells Suppress Allergic...

Researchers developed regulatory T cells armed with chimeric allergen receptors—...

ALS Drug Extends Survival in Mice, Targets TDP-43 Low-C...

A new therapeutic target shields nerve cells from the damage of ALS. A novel dru...